Fingerprint
Dive into the research topics of 'A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy
Geoffrey M. Forbes*, Marian J. Sturm, Rupert W. Leong, Miles P. Sparrow, Dev Segarajasingam, Adrian G. Cummins, Michael Phillips, Richard P. Herrmann
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
282
Citations
(Scopus)